The Alabama Medical Cannabis Commission (AMCC) approved rules Aug. 11 that will govern the medical cannabis business licensing process, according to an report.

Those seeking cultivation, processing, testing, transportation and retail licenses can request the applications starting Sept. 1, the news outlet reported.

The AMCC then plans to start accepting the applications Oct. 31, with an application deadline of Dec. 30, according to

The commission will begin awarding business licenses in June 2023, the news outlet reported, and medical cannabis products are expected to hit dispensary shelves in late 2023 or early 2024.

RELATED: Alabama Regulators Release Draft Rules for Medical Cannabis Industry

Alabama Gov. Kay Ivey signed the state’s medical cannabis program into law in May 2021.

Doctors who receive training in medical cannabis can recommend it to patients with several qualifying conditions, including autism spectrum disorder; cancer-related pain, weight loss and vomiting; Crohn’s Disease; depression; epilepsy or conditions causing seizures; HIV/AIDS-related nausea or weight loss; panic disorder; Parkinson’s Disease; persistent nausea; post-traumatic stress disorder (PTSD); sickle cell anemia; spasticity associated with multiple sclerosis or spinal cord injury; Tourette’s Syndrome; a terminal illness; and conditions causing chronic or intractable pain.

Medical cannabis will be available in tablet, capsule, tincture or gel cube form for oral use, reported, as well as topicals, suppositories, transdermal patches, nebulizers, and liquids or oils for use in an inhaler. Cannabis flower, products that can be smoked or vaped, and edible cannabis products are not permitted under Alabama’s medical cannabis law, according to the news outlet.

Generated by Feedzy